MRVI - Maravai Lifesciences Holdings  - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

MRVI is currently covered by 3 analysts with an average price target of $5.4. This is a potential upside of $2.13 (-19.76%) from yesterday's end of day stock price of $6.73.

Maravai Lifesciences Holdings 's activity chart (see below) currently has 100 price targets and 85 ratings on display. The stock rating distribution of MRVI is 75% BUY and 25% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 61.84% with an average time for these price targets to be met of 124.14 days.

Highest price target for MRVI is $8, Lowest price target is $4, average price target is $5.4.

Most recent stock forecast was given by DAN BRENNAN from UBS. First documented stock forecast 14-Dec-2020.

Best performing analysts who are covering MRVI - Maravai Lifesciences Holdings :

Paul Knight Tejas Savant Erin Wright Daniel Arias Catherine Schulte Brandon Couillard Michael Ryskin

Currently out of the existing stock ratings of MRVI, 3 are a BUY (75%), 1 are a HOLD (25%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Hold Since 08-Aug-2024

$8

$1.05 (15.11%)

$2.5

Buy Since 15-Dec-2020

$5.5

$-0.72 (-11.58%)

$4.5

4 months 3 days ago
(08-May-2026)

3/3 (100%)

$0.65 (13.40%)

80

Buy Since 15-Dec-2020

$4

$-2.22 (-35.69%)

$5

10 months 4 days ago
(07-Nov-2025)

7/14 (50%)

$1.13 (39.37%)

181

Buy Since 07-Dec-2022

$5

$-1.22 (-19.61%)

$13

1 years 30 days ago
(12-Aug-2025)

1/13 (7.69%)

$2.31 (85.87%)

297

Hold Since 13-May-2025

$2

$-4.95 (-71.22%)

1 years 3 months 29 days ago
(13-May-2025)

5/10 (50%)

$-0.06 (-2.91%)

141

Show more analysts

Please expand the browser size to see the chart

What is MRVI (Maravai Lifesciences Holdings ) average time for price targets to be met?

On average it took 124 days for the stock forecasts to be reached, with an average price target met ratio of 61.84%.

Which analyst most recently updated their price target on MRVI (Maravai Lifesciences Holdings )?

Dan Brennan

Which analyst has the most public recommendations on MRVI (Maravai Lifesciences Holdings )?

Dan Brennan works at UBS and has 40 price targets and 26 ratings on MRVI

Which analyst is the currently most bullish on MRVI (Maravai Lifesciences Holdings )?

Katie Tryhane with the highest potential upside of $50.93

Which analyst is the currently most reserved on MRVI (Maravai Lifesciences Holdings )?

Catherine Schulte with the lowest potential downside of -$4.95

To continue looking at which analysts cover the stock please register to the basic or advanced membership

To continue looking at analysts data please register to the advanced membership

What is AnaChart?